Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 ...
Leadership
James E. Dentzer
President, CEO, Secretary, Treasurer & Director
Diantha Duvall CPA, M.B.A.
CFO and Principal Financial & Accounting Officer
Jonathan B. Zung Ph.D.
Chief Development Officer
Mark W. Noel
Vice President of Technology Management & Intellectual Property
